Outcome of the public consultation on the draft EFSA Opinion on the impact of non‐monotonic dose responses on EFSA´s human health risk assessments
The European Food Safety Authority carried out a public consultation to receive input from the scientific community and all interested parties on the draft EFSA Opinion on “biological plausibility of non‐monotonic dose responses and their impact on the risk assessment”, following the consultation the title of the opinion has been modified to “the impact of non‐monotonic dose responses on EFSA´s human health risk assessments”. The draft Opinion was developed by the Scientific Committee’s Working Group on ‘non‐monotonic dose response (NMDR)’ and endorsed by the Scientific Committee for public consultation on 12 November 2020, during its 101st plenary meeting. The public consultation for this document was open from 4 December 2020 to 4 February 2021. During this period, EFSA received contributions from 25 interested parties belonging to different sectors (e.g. EU and extra‐EU institutions, national authorities, universities and public research institutes, international organisations, NGOs, and industry associations). EFSA and its Scientific Committee wish to thank all the stakeholders for their contributions. This report presents the comments received and addressed after consideration by the Scientific Committee’s Working Group on ‘non‐monotonic dose response (NMDR)’ and discussion at the 105th Scientific Committee plenary meeting of 22 September 2021.
This publication is linked to the following EFSA Journal article: http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2021.6877/full